[Alliance for Cancer Gene Therapy](https://acgtfoundation.org)

Rolling

Typically $250,000–$500,000 per award; award size and duration may vary by project.

Supports biotech companies developing cell and gene therapies targeting glioblastoma and pancreatic cancer, with a focus on clinical breakthroughs and sustainability.

Open only to biotech companies; academic institutions and other organizations are not eligible.

--- ## Description The Alliance for Cancer Gene Therapy's Biotech funding program aims to accelerate the development of cell and gene therapy projects focused on glioblastoma and pancreatic cancer—two of the most challenging and underfunded solid tumor cancers. The program seeks applications from biotech companies with robust scientific foundations and clear clinical development pathways. Projects should demonstrate significant promise for patient impact and the potential for a financial return to help sustain future innovative research. The initiative is guided by a Scientific Advisory Council and Board of Directors, ensuring scientific rigor and strategic alignment with the organization’s mission to foster sustainable cycles of funding and advance new cancer treatments. --- ## Due Dates - Rolling submissions; applications are accepted at any time. --- ## Funding Amount - Typical awards range from **$250,000 to $500,000** per project. - Award size and duration may be tailored to the specifics of each proposal. - Funding is competitive and focused on projects with high potential for clinical impact. --- ## Eligibility - **Eligible Applicants:** Only biotech companies (for-profit or nonprofit) are eligible to apply. - **Project Focus:** Projects must be in cell and gene therapy and directly target glioblastoma and/or pancreatic cancer. - **Other Organizations:** Academic investigators and other types of organizations are not eligible for this program. - **Geography:** There is no citizenship requirement, but projects are generally expected to be conducted in the U.S. or Canada. --- ## Application Process - **Initial Contact:** Interested biotech companies should contact Barbara Lavery, Chief Program Officer, at [blavery@acgtfoundation.org](mailto:blavery@acgtfoundation.org), or complete the [online application form](https://acgtfoundation.org/biotech-funding-application). - **Application Materials:** Applicants must provide: - Company and contact information - Management team and scientific advisors - Details on current and past funding - Project summary and budget estimate - Corporate presentation/investor deck (PPT or PDF) - Detailed project proposal outlining the unmet need, scientific rationale, and how ACGT funding will be used - **Review Process:** Proposals are reviewed by the Scientific Advisory Council and Board of Directors for scientific merit, clinical potential, and alignment with program goals. --- ## Additional Information - The program prioritizes projects with a strong clinical development path and potential for both patient and financial impact. - The focus is on solid tumor cancers with high morbidity and low investment, specifically glioblastoma and pancreatic cancer. - For more information on what the funder supports and profiles of past funded projects, visit the [What We Fund](https://acgtfoundation.org/groundbreaking-research/what-we-fund/) page. --- ## External Links - [Biotech Funding Program Overview](https://acgtfoundation.org/groundbreaking-research/biotech-funding-program/) - [Biotech Funding Application Form](https://acgtfoundation.org/biotech-funding-application) - [Apply for Funding – FAQs](https://acgtfoundation.org/groundbreaking-research/apply-for-funding/) - [Scientific Advisory Council](https://acgtfoundation.org/role/sac/) - [Board of Directors](https://acgtfoundation.org/role/bod/) - [Contact Page](https://acgtfoundation.org/who-we-are/contact-us/) --- ## Contact Information | Name/Role | Email | Phone | |--------------------------|---------------------------------------------|-----------------| | Barbara Lavery, Chief Program Officer | [blavery@acgtfoundation.org](mailto:blavery@acgtfoundation.org) | +1 203-358-5055 | | General Inquiries | [Contact Form](https://acgtfoundation.org/who-we-are/contact-us/) | |

Biotech funding program

Sign in to see full grant listing